Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market to Reach $7.8 Billion by 2030
The global market for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers estimated at US$4.6 Billion in the year 2022, is projected to reach a revised size of US$7.8 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2022-2030. Hemostats, one of the segments analyzed in the report, is projected to record 7.4% CAGR and reach US$3.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Internal Tissue Sealants segment is readjusted to a revised 6.4% CAGR for the next 8-year period.The U.S. Market is Estimated at $1.3 Billion, While China is Forecast to Grow at 11.3% CAGR
The Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers market in the U.S. is estimated at US$1.3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2030 trailing a CAGR of 11.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.8% and 6.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.Select Competitors (Total 44 Featured) -
- Axio Biosolutions Private Limited
- Beacon Senior Advisors
- Chitogen, Inc.
- Corlison Pte. Limited
- Ethicon US LLC
- GELITA MEDICAL
- LifeBond Ltd.
- Tissuemed Ltd.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Axio Biosolutions Private Limited
- Beacon Senior Advisors
- Chitogen, Inc.
- Corlison Pte. Limited
- Ethicon US LLC
- GELITA MEDICAL
- LifeBond Ltd.
- Tissuemed Ltd.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 193 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 4.6 Billion |
Forecasted Market Value ( USD | $ 7.8 Billion |
Compound Annual Growth Rate | 6.8% |
Regions Covered | Global |